Joel Block to United States
This is a "connection" page, showing publications Joel Block has written about United States.
Connection Strength
0.472
-
Validation of SIMPLE Index for Lupus Disease Activity. J Clin Rheumatol. 2018 Sep; 24(6):313-318.
Score: 0.098
-
Retrospective Study of Patients on Etanercept Therapy for Rheumatic Diseases in Patients With Chronic Hepatitis C Virus. J Clin Rheumatol. 2017 Aug; 23(5):252-257.
Score: 0.091
-
Tuberculosis infections and tumor necrosis factor alpha antagonists. Am J Ther. 2013 Jan; 20(1):73-8.
Score: 0.066
-
LupusQoL-US benchmarks for US patients with systemic lupus erythematosus. J Rheumatol. 2010 Sep; 37(9):1828-33.
Score: 0.056
-
Lupus-specific health outcome measure for US patients: the LupusQoL-US version. Ann Rheum Dis. 2010 Jan; 69(1):29-33.
Score: 0.054
-
Functional Status Measures and Indices in Rheumatoid Arthritis: Comment on the Articles by Barber et al and England et al. Arthritis Care Res (Hoboken). 2020 08; 72(8):1185-1186.
Score: 0.028
-
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2020 02; 72(2):149-162.
Score: 0.027
-
Sex Differences in Quality of Life in Patients With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2019 12; 71(12):1647-1652.
Score: 0.025
-
Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum. 2012 Aug; 42(1):56-65.
Score: 0.016
-
Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin Infect Dis. 2004 Aug 01; 39(3):295-9.
Score: 0.009